GIM
MDT icon

Granahan Investment Management’s Medtronic MDT Stock Holding History

Granahan Investment Management’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-3,028
Closed -$235K – 235
2017
Q3 		$235K Sell
3,028
-2,520
-45% -$209K 0.02% 216
2017
Q2 		$492K Buy
5,548
+234
+4% +$19.7K 0.05% 168
2017
Q1 		$428K Sell
5,314
-206
-4% -$16.1K 0.04% 165
2016
Q4 		$393K Buy
5,520
+899
+19% +$70.6K 0.01% 186
2016
Q3 		$399K Buy
+4,621
New +$403K 0.01% 202

Other funds holding MDT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Granahan Investment Management's MDT Position: Q4 2017 in Review

Granahan Investment Management sold out of Medtronic (MDT) in Q4 2017, closing a stake of 3,028 shares — an estimated $235K sold.

Granahan Investment Management first reported a position in MDT in Q3 2016 and held it in 5 quarters. The position peaked at $492K in Q2 2017. 1,408 funds tracked by Wall St. Rank hold MDT as of Q4 2017.

  • Granahan Investment Management reported no remaining Medtronic position as of Q4 2017 after selling out during the quarter.
  • Granahan Investment Management sold 3,028 Medtronic shares in Q4 2017, an estimated $235K.
  • Granahan Investment Management first reported a position in Medtronic in Q3 2016 and held it in 5 quarters.
  • Granahan Investment Management's Medtronic position peaked at $492K in Q2 2017.
  • 1,408 funds tracked by Wall St. Rank held Medtronic as of Q4 2017.

Based on Granahan Investment Management's 13F filing for Q4 2017, filed 12 Feb 2018.